Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2021 07:45 ET | Source: Progenity, Inc.

Progenity Announces $25 Million Private Placement

SAN DIEGO, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing...
February 18, 2021 08:01 ET | Source: Pacific Biosciences of California, Inc.

Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

MENLO PARK, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that...
February 18, 2021 07:58 ET | Source: Research and Markets

Global Women’s Health Diagnostics Market Report 2021 - Market is Projected to Reach $36.6 Billion by 2025 from $25.0 Billion in 2020

Dublin, Feb. 18, 2021 (GLOBE NEWSWIRE) -- The "Women's Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis,...
February 18, 2021 01:00 ET | Source: Biocartis NV

Persbericht Biocartis Group NV: BIOCARTIS KONDIGT 2020 JAARRESULTATEN AAN OP 25 FEBRUARI 2021

PERSBERICHT: GEREGLEMENTEERDE INFORMATIE18 februari 2021, 07:00 CET BIOCARTIS KONDIGT 2020 JAARRESULTATEN AAN OP 25 FEBRUARI 2021 Mechelen, België, 18 februari 2021 – Biocartis Group NV (de...
February 18, 2021 01:00 ET | Source: Biocartis NV

Press news Biocartis Group NV: BIOCARTIS ANNOUNCES 2020 FULL YEAR RESULTS ON 25 FEBRUARY 2021

PRESS RELEASE: REGULATED INFORMATION 18 February 2021, 07:00 CET BIOCARTIS ANNOUNCES 2020 FULL YEAR RESULTS ON 25 FEBRUARY 2021 Mechelen, Belgium, 18 February 2021 – Biocartis Group NV (the...
February 17, 2021 07:30 ET | Source: Progenity, Inc.

Progenity Initiates Safety and Tolerability Study of its Smart Capsule-Based Oral Drug Delivery System for GI Diseases

SAN DIEGO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...
February 17, 2021 07:08 ET | Source: Research and Markets

Worldwide Respiratory Disease Testing Industry to 2026 - by Type, Application, End-user and Country

Dublin, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Disease Testing Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country,...
February 12, 2021 07:30 ET | Source: Progenity, Inc.

SMFM Conference and Publications Highlight the Challenges and Complexities of Diagnosing and Managing Preeclampsia

SAN DIEGO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
February 11, 2021 13:10 ET | Source: Market Research Future

Hba1c Testing Market Size to Cross USD 1,992.44 Mn by 2025 at 12.24% CAGR| Rise in Adoption of Micro-Optical Detection Method to Benefit Industry Growth, Says Market Research Future (MRFR)

Pune, India, Feb. 11, 2021 (GLOBE NEWSWIRE) -- HbA1c Testing market Overview: Market Research Future (MRFR) analyzed the global HbA1c Testing Market in the review period between 2020 and 2025. MRFR...
February 11, 2021 11:14 ET | Source: Priveterra Acquisition Corp

Priveterra Acquisition Corp. Announces Closing of $276 Million Initial Public Offering

FORT LAUDERDALE, Fla., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Priveterra Acquisition Corp. (Nasdaq: PMGMU) (the “Company”) today announced that it closed its initial public offering of 27,600,000 units....